glp 1 and alcohol consumption GLP-1 Anti-Obesity Rx and Substance Use Disorders GLP-1s IMPACT ON ALCOHOL |

Researchers study AOD9604 to explore signaling pathways associated with adipose-related cellular processes and metabolic regulation models

Improve muscle mass, strength, and body composition

an extreme increase in activity and talking

Dose-by-dose weight loss in Phase 2 (NEJM) Phase 2 NEJM weight loss by dose, 24 and 48 weeks Dose 1 mg 24 weeks -7.2% 48 weeks -8.7% Dose 4 mg 24 weeks -12.9% 48 weeks -17.5% Dose 8 mg 24 weeks -15.7% 48 weeks -22.8% Dose 12 mg 24 weeks -17.5% 48 weeks -24.2% Dose Placebo 24 weeks -1.6% 48 weeks -2.1% Source: Jastreboff et al., NEJM 2023

Myo-inositol is one of the most extensively studied nutritional compounds in the field of reproductive endocrinology and metabolic medicine over the past 15 years